Precision BioSciences, Inc. (DTIL)
NASDAQ: DTIL · IEX Real-Time Price · USD
9.38
-0.34 (-3.50%)
At close: Apr 26, 2024, 4:00 PM
9.70
+0.32 (3.41%)
After-hours: Apr 26, 2024, 7:14 PM EDT

Precision BioSciences Revenue

In the year 2023, Precision BioSciences had annual revenue of $48.73M with 94.15% growth. Revenue in the quarter ending December 31, 2023 was $7.04M, a -33.59% decrease year-over-year.

Revenue (ttm)
$48.73M
Revenue Growth
+94.15%
P/S Ratio
1.33
Revenue / Employee
$447,037
Employees
109
Market Cap
64.87M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202348.73M23.63M94.15%
Dec 31, 202225.10M-90.43M-78.28%
Dec 31, 2021115.53M91.24M375.72%
Dec 31, 202024.29M2.05M9.20%
Dec 31, 201922.24M11.36M104.34%
Dec 31, 201810.88M4.40M67.84%
Dec 31, 20176.48M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Journey Medical 79.18M
Personalis 73.48M
MDxHealth 70.19M
Champions Oncology 49.22M
Asensus Surgical 8.58M
Silver Spike Investment 7.76M
Cue Biopharma 5.49M
Revenue Rankings